Taylor Wessing advised Apollo Therapeutics on its series C funding round. Apollo Therapeutics Limited, a biopharmaceutical company headquartered in Cambridge, has successfully raised $226.5 million in...
Apollo Therapeutics’ $226.5m Series C Financing
Apollo Thereapeutics’ $145 Million Financing
Taylor Wessing advised Apollo Therapeutics, while Kirkland & Ellis advised Patient Square Capital on the deal. Led by Patient Square Capital, and with participation from additional...